Awareness Towards Gastrointestinial Bleeding Amongst Patients With Bleeding Disorder By Fatimid Foundation

Usually any kind of bleeding that involves the gastrointestinal track is referred to as gastrointestinal bleeding. This means over a short period of time a significant amount of blood loss occurs. Symptoms may consist of vomiting blood or observing colored or bloody stool and diagnosis generally begins with a medical history and physical examination, followed by blood tests. 

But circumstances get more alarmingly critical when it involves a patient of hemophilia going through the misery of gastrointestinal bleeding. The above mentioned bleeding disorders includes Hemophilia A (factor VIII deficiency), Hemophilia B (factor IX deficiency), Von Willebrand disease, Rare factor deficiencies including I, II, V, VII, X, XI, XII and XIII, Platelet function disorders. Over up to 25% of such patients have a chance of suffering from gastrointestinal bleeding as well. The central risk factors can be classified into two:

Helicobacter pylori (H. pylori) infection: is a common type of bacteria grown infection in the digestive tract that has a tendency to attack the stomach lining.

Angiodysplasia:

•  a small vascular malformation of the gut.
• It is common for a person with bleeding disprder to have same illnesses as other people, such as appendicitis, pancreatitis, or a peptic ulcer

It is extremely common for a person with a bleeding disorder to have the same illnesses as other people, such as appendicitis, pancreatitis, or a peptic ulcer. So to confirm if the patient has gastrointestinal bleeding there are a few general symptoms:

• Vomiting fresh (red) blood or old (coffee grounds) blood.
• Passing bloody or black tar like stool while they have a bowel movement.
• Pain in stomach area.
• Stomach pain.
• Pale look.

To treat such patients, their factor levels should be raised immediately and should be maintained until their hemorrhage has stopped and etiology is defined. Origins of hemorrhage should be treated along with anemia and shock and hemoglobin levels should be monitored on a regular basis. 

Tranexamic acid or EACA may be used as adjunctive therapy for patients with Factor VIII deficiency and those with Factor IX deficiency who are not being treated with prothrombin complex concentrates. The treatment needs to be handled carefully and therefore it is always a smart move to involve professional care. 

To attain such professional and elaborate care one can always head towards Fatimid Foundation. To find out about what care Fatimid Foundation provides visit https://fatimid.org/